NAT:NYSENordic American Tankers Limited Analysis
Data as of 2026-05-31 - not real-time
$5.15
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Nordic American Tankers is trading at $5.15, comfortably above its DCF‑derived fair value of $4.46 and far above the industry average P/E of 20, indicating a potentially overvalued stock. The company boasts an eye‑catching dividend yield of 17.09% and a modest payout ratio, yet free cash flow is negative and debt‑to‑equity sits at an alarming 91, raising questions about dividend sustainability. Recent contract wins have lifted vessel utilization to $68,000 per day in Q2, up from $47,600 in Q1, supporting near‑term revenue, but the broader energy midstream sector remains volatile amid Middle‑East tensions. Technical signals are mixed: RSI at 36 hints at slight oversold conditions, while a bearish MACD and price hovering just above the $5.02 support level suggest limited upside in the short run.
Given the high volatility (36% 30‑day), low beta (0.22), and a neutral trend, investors should weigh the generous dividend against the company’s cash‑flow strain and elevated leverage before making a move.
Given the high volatility (36% 30‑day), low beta (0.22), and a neutral trend, investors should weigh the generous dividend against the company’s cash‑flow strain and elevated leverage before making a move.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support with bearish MACD
- High dividend yield but questionable cash‑flow backing
- Increasing volume suggests some buying interest
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Improved vessel utilization rates supporting revenue
- Elevated leverage and negative free cash flow
- Valuation still above fair value despite modest upside potential
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Persistent overvaluation relative to fundamentals
- High debt load and limited earnings growth
- Dividend sustainability concerns amid cash‑flow weakness
Key Metrics & Analysis
Financial Health
Revenue Growth109.00%
Profit Margin16.27%
P/E Ratio85.8
ROE11.36%
ROA4.84%
Debt/Equity91.11
P/B Ratio2.4
Op. Cash Flow$50.4M
Free Cash Flow$-98511248
Industry P/E20.5
Technical Analysis
TrendNeutral
RSI36.6
Support$5.02
Resistance$6.02
MA 20$5.57
MA 50$5.67
MA 200$4.27
MACDBearish
VolumeIncreasing
Fear & Greed Index94.07
Valuation
Fair Value$4.46
Target Price$6.00
Upside/Downside16.50%
GradeOvervalued
TypeValue
Dividend Yield17.09%
Risk Assessment
Beta0.22
Volatility36.22%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.